Skip to main content

Strange But Useful

Thomas Brock and Hudson Freeze were among the investigators honored at this year's Golden Goose Award ceremony. The award highlights basic — and sometimes odd-sounding — federally funded research that has had an effect on society.

The award name references both Aesop's fable of the goose that laid the golden egg as well as the Golden Fleece Award that former Sen. William Proxmire (D-Wisc.) would bestow on research he considered wasteful, LiveScience adds. The Golden Goose Award started last year by Rep. Jim Cooper (D-Tenn.) and is sponsored by a number of science and university groups, such as the American Association for the Advancement of Science and the Association of American Universities

Funded by the National Science Foundation, Brock and Freeze studied microorganisms living in Yellowstone Park, and their discovery of a heat-resistant microbe has enabled countless PCR reactions and modern molecular biology.

Other awardees include John Eng, a physician whose studies of Gila monster venom led to a drug to prevent complications from diabetes, and David Gale, Lloyd Shapley, and Alvin Roth, whose work in theoretical mathematics on marriage stability has been implemented in the national program that matches kidney donors and patients and elsewhere. Shapley and Roth won the Nobel Prize for their work in 2012; Dale died in 2008.

"It's easy to mock researchers, but we couldn't live without their brilliant breakthroughs," Cooper said in a statement. "Today's awardees gave unexpected gifts to mankind. Fiscal discipline is important, but without science we'll never see the next discovery."

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.